Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$135.29−21.27 (-13.59%)

Close on Nov 12, 2026Market cap $5.65BP/E –Yield –

Veradermics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Veradermics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?